Navigation Links
Why is the measles virus so contagious?
Date:11/4/2011

An international collaboration involving Inserm has revealed how the measles virus leaves the body of an infected person to contaminate another individual. The researchers have identified a key receptor, located in the trachea, which allows the virus to spread through the air rapidly from one organism to another. The receptor, nectine-4, is also known to be a biomarker for some cancers.

This research appeared in a letter, dated 2 November 2011, published in Nature.

The measles virus is one of the most highly contagious human pathogens and can cause serious, sometimes fatal, complications. It is mainly transmitted when an infected person coughs or sneezes, sending droplets through the air to another individual. This explains why the virus spreads so rapidly through at-risk populations (i.e. persons who are not vaccinated or improperly vaccinated), obstructing world vaccination programmes that seek to eradicate it. Every year, this virus infects more than 10 million children and causes 120,000 deaths in the world. France also faces a measles epidemic that is giving cause for concern. While only forty or so cases were reported in 2006 and 2007, numbers have risen sharply since 2008 (14,600 cases have already been reported since the beginning of 2011) .

The discovery published in the journal Nature explains why this virus spreads so quickly. Viruses generally use cell receptors to initiate and spread the infection throughout the organism. This is the case of the measles virus, which infects the immune cells in the lungs to enter and spread through the body. For the first time ever, this study shows how the measles virus uses another receptor (nectine-4) to 'leave' its host. Nectine-4 is located specifically in the trachea, a part of the anatomy that is 'ideally' suited to airborne contagion.

Interesting prospects for cancer treatment

Nectine-4 is a biomarker for certain types of cancer, including breast, ovarian and lung cancer. Treatments based on the use of a modified vaccine strain of the measles virus are currently being developed for use against some cancers. This virus replicates preferentially in cancer cells, leading to their destruction. The presence of this biomarker in tumours must be taken into consideration to improve the efficacy of these novel therapeutic methods.


'/>"/>

Contact: Inserm Press Office
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related biology news :

1. Researchers test inhalable measles vaccine
2. Measles virus plays role in Pagets disease of bone, Pitt-led team says
3. Measles virus, a weapon against cancer?
4. Mayo researchers describe measles viral protein movement
5. West Nile virus transmission linked with land-use patterns and super-spreaders
6. Scientists report major advance in human antibody therapy against deadly Hendra virus
7. Pitt biologists find surprising number of unknown viruses in sewage
8. Manipulated gatekeeper: How viruses find their way into the cell nucleus
9. XMRV, related viruses not confirmed in blood of healthy donors or chronic fatigue syndrome patients
10. Cowpox virus: Old friend but new foe
11. Team finds stable RNA nano-scaffold within virus core
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... 2, 2016 This BCC Research report ... by reviewing the recent advances in high throughput ... the field forward. Includes forecast through 2019. ... challenges and opportunities that exist in the bioinformatic ... developers, as well as IT and bioinformatics service ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... 2016  Wellcentive today announced it has been ... -based community care organization (CCO) with more ... quality reporting and care management solutions and services. ... of quality managers, analysts and care managers while ... serving FamilyCare members. Oregon ...
(Date:2/11/2016)... 2016   BioInformant announces the February 2016 ... Products, Opportunities, Tools, and Technologies – Market Size, Segments, ... The first and only ... industry, BioInformant has more than a decade of historical ... by stem cell type. This powerful 175 page global ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... -- ASAE is introducing a hybrid membership model which ... option of joining or renewing through an organizational purchasing ... size, every employee in any size association or AMC ... available member benefits.   John H. Graham, ... will allow organizations of any size and their employees ...
Breaking Biology Technology: